Emerging Data on Diabetes and COVID-19 Reassuring Emerging Data on Diabetes and COVID-19 Reassuring

Two new studies add to evidence that most people with type 1 diabetes are not at excessively higher risk for COVID-19 mortality than the general population.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Related Links:

Two new studies add to evidence that most people with type 1 diabetes are not at excessively higher risk for COVID-19 mortality than the general population.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news
AbstractAimsBillions of people have been under lockdown in an attempt to prevent COVID-19 spread. Lifestyle changes during lockdown could lead to deterioration of glycemic control in type 1 diabetes (T1D). We aimed to assess the impact of COVID-19 lockdown on the glycemic control of pediatric patients with T1D.MethodsThis observational real-life study from the AWeSoMe Group assessed continuous glucose monitoring (CGM) metrics of 102 T1D patients (52.9% males, mean age 11.2  ± 3.8 years, mean diabetes duration 4.2 ± 3.8 years) who used  Dexcom G5. The data were access...
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
MONDAY, Oct. 5, 2020 -- When the COVID-19 pandemic began, many doctors started providing care via telemedicine. Now, a new survey of people with type 1 diabetes suggests many like remote care and hope it continues in the future. Among the survey...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Survey finds patients with type 1 diabetes generally view pandemic-imposed telemedicine visits favorably, regardless of age and education level.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
The recent Covid-19 pandemic has accelerated the treatment process through IT / technological supports, useful in the management of chronic patients such as those affected by type 1 Diabetes Mellitus (T1DM). Specific routes for fragile patients such as those with micro-infusers have been created thanks to the application of “Diabetes Technology,” which allows patients to monitor blood glucose quickly and easily. The present pilot study aimed to assess the quality of care provided to patients with micro-infusers in a delicate phase such as a pandemic lockdown.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research
The aim of this study was to evaluate the effect the lockdown imposed during COVID-19 outbreak on the glycemic control of people with Type 1 diabetes (T1D) using Continuous (CGM) or Flash Glucose Monitoring (FGM).
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research
Conditions:   Type 1 Diabetes Mellitus;   Covid19 Intervention:   Other: Online Survey Sponsor:   Gazi University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractBackgroundStrict isolation measures and interrupted health care services during the COVID 19 pandemic are contemplated to instigate stress universally, particularly in those with chronic illnesses such as type 1 diabetes (T1D).MethodsA cross-sectional, observational study was done to assess determinants of stress and its impact on glycemic control in adolescents and young adults (aged 12 –24 years) living with T1D in India. An online, semi-structured survey including Perceived Stress Scale (PSS-10) was distributed and results were analyzed.ResultsA total of 89 participants (46 males, mean age 19.61 &thin...
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research
ConclusionsChildren and adolescents having T1DM require special care and attention during this period of COVID-19 pandemic because of various challenges as discussed. Our proposed solutions may help them overcome these problems and help them in better diabetes management during such emergency situations.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research
Authors: Sinha S, Sehgal A, Sehgal R Abstract Coronavirus disease 2019 (COVID-19) is found to be associated with various comorbidities which include cardiovascular diseases, hypertension, and diabetes. The impaired regulation of renin-angiotensin-aldosterone system (RAAS) has been seen in COVID-19 patients, but whether RAAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), are responsible for worsening of clinical conditions remains unknown. Herein, we review the role of angiotensin-converting enzyme 2 (ACE2) expression in disease progression, i...
Source: Drug Discoveries and Therapeutics - Category: Drugs & Pharmacology Tags: Drug Discov Ther Source Type: research
More News: COVID-19 | Diabetes | Diabetes Type 1 | Endocrinology | Primary Care | Study